Interestingly, lower CBF correlated with lower levels of fatigue at 3 months, alongside a weak trend for a reduction in CBF after 3 months of treatment with adalimumab.
← all excerpts
Disease activity and cognition in rheumatoid arthritis: an open label pilot study.
1
—
—